Aguilar-Cordova Estuardo
Insider CIK 1873919 · CADL Chief Scientific Officer, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CADL Candel Therapeutics, Inc. | D To issuer | 2025-02-21 | 2025-02-25 | 10,582 | $12.02 | $127.2K | 120,861 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2025-02-21 | 2025-02-25 | 10,583 | $12.02 | $127.2K | 162,929 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2025-02-10 | 2025-02-13 | 31,335 | $8.61 | $269.8K | 60,000 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-27 | 2024-12-30 | 50,000 | $8.85 | $442.5K | 131,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-27 | 2024-12-30 | 50,000 | $8.85 | $442.5K | 173,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-26 | 2024-12-30 | 50,000 | $9.01 | $450.5K | 181,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-26 | 2024-12-30 | 50,000 | $9.01 | $450.5K | 223,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-24 | 2024-12-26 | 50,000 | $8.82 | $441.0K | 231,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-24 | 2024-12-26 | 50,000 | $8.82 | $441.0K | 273,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-23 | 2024-12-26 | 50,000 | $8.52 | $426.0K | 281,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-23 | 2024-12-26 | 50,000 | $8.52 | $426.0K | 323,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-20 | 2024-12-26 | 100,000 | $9.00 | $900.0K | 373,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-20 | 2024-12-26 | 100,000 | $9.00 | $900.0K | 331,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-12 | 2024-12-13 | 200,000 | $10.04 | $2.01M | 473,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-12 | 2024-12-13 | 200,000 | $10.04 | $2.01M | 431,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-11 | 2024-12-13 | 200,000 | $8.53 | $1.71M | 631,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-11 | 2024-12-13 | 200,000 | $8.53 | $1.71M | 673,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-06 | 2024-12-06 | 20,000 | $5.23 | $104.6K | 91,335 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-05 | 2024-12-06 | 20,000 | $4.79 | $95.8K | 111,335 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-12-04 | 2024-12-06 | 20,000 | $4.46 | $89.2K | 131,335 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-25 | 2024-11-27 | 20,000 | $4.97 | $99.4K | 151,335 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-08 | 2024-11-08 | 7,500 | $4.92 | $36.9K | 873,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-08 | 2024-11-08 | 7,500 | $4.92 | $36.9K | 831,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-07 | 2024-11-08 | 7,500 | $5.19 | $38.9K | 881,012 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-07 | 2024-11-08 | 7,500 | $5.19 | $38.9K | 838,943 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-06 | 2024-11-08 | 7,500 | $5.33 | $40.0K | 846,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-06 | 2024-11-08 | 7,500 | $5.33 | $40.0K | 888,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-01 | 2024-11-01 | 7,500 | $5.27 | $39.5K | 853,943 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-11-01 | 2024-11-01 | 7,500 | $5.27 | $39.5K | 896,012 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-10-31 | 2024-11-01 | 7,500 | $5.30 | $39.8K | 861,443 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-10-31 | 2024-11-01 | 7,500 | $5.30 | $39.8K | 903,512 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-10-30 | 2024-11-01 | 6,000 | $5.38 | $32.3K | 868,943 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-10-30 | 2024-11-01 | 6,000 | $5.38 | $32.3K | 911,012 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-10-28 | 2024-10-28 | 11,711 | $5.58 | $65.3K | 888,532 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-10-25 | 2024-10-28 | 1,597 | $5.80 | $9.3K | 900,243 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-10-24 | 2024-10-28 | 1,194 | $5.72 | $6.8K | 901,840 | SEC↗ |
| CADL Candel Therapeutics, Inc. | D To issuer | 2024-10-24 | 2024-10-28 | 16,427 | $5.53 | $90.8K | 903,034 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-10-15 | 2024-10-15 | 10,412 | $6.03 | $62.8K | 919,461 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-10-14 | 2024-10-15 | 15,000 | $6.02 | $90.3K | 929,873 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-10-11 | 2024-10-15 | 15,000 | $6.05 | $90.8K | 944,873 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-10-03 | 2024-10-03 | 1,800 | $6.85 | $12.3K | 959,873 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-10-02 | 2024-10-03 | 26,988 | $6.92 | $186.8K | 961,673 | SEC↗ |
| CADL Candel Therapeutics, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 6,214 | $7.01 | $43.6K | 988,661 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2023-06-28 | 2023-06-29 | 14,240 | — | $0 | 14,240 | SEC↗ |
| CADL Candel Therapeutics, Inc. | A Award deriv | 2022-10-13 | 2022-10-17 | 14,240 | — | $0 | 14,240 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise deriv | 2022-05-06 | 2022-05-10 | 46,261 | — | $0 | 30,456 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise deriv | 2022-05-06 | 2022-05-10 | 12,205 | — | $0 | 0 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise deriv | 2022-05-06 | 2022-05-10 | 76,717 | — | $0 | 0 | SEC↗ |
| CADL Candel Therapeutics, Inc. | F Tax w/h | 2022-05-06 | 2022-05-10 | 54,074 | $3.65 | $197.4K | 1,097,032 | SEC↗ |
| CADL Candel Therapeutics, Inc. | M Exercise | 2022-05-06 | 2022-05-10 | 135,183 | $1.46 | $197.4K | 1,151,106 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion deriv | 2021-07-29 | 2021-08-02 | 398,519 | — | $0 | 0 | SEC↗ |
| CADL Candel Therapeutics, Inc. | C Conversion | 2021-07-29 | 2021-08-02 | 162,137 | — | $0 | 1,015,923 | SEC↗ |